| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,125 |
10,348 |
$1.46M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,726 |
4,984 |
$762K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,168 |
1,014 |
$393K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,936 |
1,702 |
$265K |
| 80053 |
Comprehensive metabolic panel |
19,088 |
15,133 |
$228K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,490 |
1,598 |
$119K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
25,633 |
20,068 |
$100K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,060 |
952 |
$82K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,867 |
1,678 |
$67K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,582 |
4,158 |
$63K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,868 |
1,679 |
$55K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
303 |
210 |
$46K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
598 |
572 |
$39K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,757 |
3,088 |
$36K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
202 |
73 |
$34K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,715 |
606 |
$31K |
| 70450 |
Computed tomography, head or brain; without contrast material |
165 |
124 |
$29K |
| 97161 |
|
169 |
161 |
$28K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,403 |
1,863 |
$25K |
| 97535 |
Self-care/home management training, each 15 minutes |
555 |
174 |
$25K |
| 80061 |
Lipid panel |
1,910 |
1,783 |
$24K |
| 71046 |
Radiologic examination, chest; 2 views |
532 |
395 |
$20K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
30 |
14 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
10,384 |
7,258 |
$18K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,630 |
1,432 |
$17K |
| 64483 |
|
14 |
14 |
$11K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
234 |
172 |
$11K |
| 80305 |
|
788 |
419 |
$10K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
336 |
318 |
$10K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
154 |
149 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
1,213 |
1,043 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
703 |
671 |
$9K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
68 |
50 |
$9K |
| 83690 |
|
1,429 |
1,084 |
$6K |
| 88142 |
|
366 |
349 |
$6K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
266 |
220 |
$6K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
107 |
100 |
$6K |
| 81001 |
|
1,211 |
956 |
$5K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
61 |
55 |
$5K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
12 |
$4K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
130 |
51 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
989 |
814 |
$3K |
| 97162 |
|
93 |
83 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
174 |
164 |
$3K |
| 87081 |
|
232 |
189 |
$2K |
| 81003 |
|
625 |
475 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
13 |
12 |
$2K |
| 88174 |
|
167 |
165 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
58 |
50 |
$2K |
| 85027 |
|
451 |
291 |
$2K |
| 80055 |
|
100 |
93 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
78 |
72 |
$2K |
| 87186 |
|
155 |
129 |
$1K |
| 87653 |
|
42 |
38 |
$1K |
| 84484 |
|
273 |
208 |
$1K |
| 82607 |
|
89 |
80 |
$1K |
| 87077 |
|
155 |
129 |
$1K |
| 87070 |
|
167 |
156 |
$1K |
| 84439 |
|
117 |
111 |
$940.80 |
| 81002 |
|
357 |
264 |
$818.21 |
| 73630 |
|
15 |
14 |
$810.10 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,317 |
1,193 |
$608.85 |
| 85651 |
|
147 |
137 |
$510.97 |
| 85610 |
|
150 |
114 |
$497.20 |
| 86803 |
|
57 |
56 |
$473.43 |
| 81025 |
|
65 |
49 |
$440.10 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,284 |
1,117 |
$438.54 |
| 82728 |
|
31 |
29 |
$435.25 |
| 83615 |
|
249 |
156 |
$419.19 |
| 86140 |
|
76 |
65 |
$389.94 |
| 85380 |
|
47 |
43 |
$389.35 |
| 83721 |
|
34 |
30 |
$369.00 |
| 83550 |
|
30 |
30 |
$315.84 |
| 84702 |
|
16 |
13 |
$270.60 |
| 83540 |
|
34 |
32 |
$248.50 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
30 |
28 |
$233.90 |
| 84481 |
|
13 |
13 |
$218.50 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
18 |
12 |
$155.21 |
| 86901 |
|
34 |
25 |
$151.80 |
| 83735 |
|
20 |
14 |
$147.05 |
| 86900 |
|
34 |
25 |
$112.50 |
| 84703 |
|
33 |
30 |
$108.87 |
| 82248 |
|
13 |
12 |
$84.11 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,610 |
1,396 |
$70.30 |
| J3490 |
Unclassified drugs |
3,239 |
2,040 |
$56.51 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,071 |
943 |
$29.23 |
| 83605 |
|
15 |
12 |
$21.36 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
44 |
39 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
83 |
70 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
17 |
13 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
21 |
18 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
255 |
240 |
$0.00 |